Minimal residual disease following autologous stem cell transplant in myeloma: impact on outcome is independent of induction regimen

HAEMATOLOGICA

FERRATA STORTI FOUNDATION

1. Medical Research Council [MR/L01629X/1, G0100132] Funding Source: Medline
2. MRC [G0100132, MR/L01629X/1] Funding Source: UKRI
3. Medical Research Council [G0100132, MR/L01629X/1] Funding Source: researchfish